Thursday 18th September, 2025 - Main Conference Day Two - ET (Eastern Time, GMT-05:00)
- Francesca Vitelli, PhD - Former, VP Cell Therapy and Viral Vector PD and MSAT, Intellia Therapeutics, Inc
- Jeffrey Masten - Senior Vice President CMC, Secretome Therapeutics
- Kate Rochlin - Chief Operating Officer, IN8bio
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Nicola Ambler - Co-Founder, CGT Circle
- Justin Skoble - Vice President of Technical Development, Caribou Biosciences, Inc.
- Monica Raimo - Director, Product and Process Development, Glycostem Therapeutics
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Rajeev Boregowda - Associate Director, Bioassay & Molecular Analytical Development, Genomic Medicine CMC, Sanofi
- Sarah Ralston Thomas - SVP, Quality, REGENXBIO
- Ying Cai - MSAT Executive Director, Ultragenyx Pharmaceutical
Spotlight Presentation – Calling all Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Victor Manuel Diaz Cortes - Research Director, OneChain Immunotherapeutics S.L.
Through a series of case studies this session will focus on the latest innovations and advances in next-generation therapies.
Explore cutting-edge preclinical and clinical case studies driving the future of cell and gene therapy.
Discover how data-driven innovation is transforming therapy development, from control and targeting to tackling undruggable diseases.
Unpack the challenges vs. traditional approaches, advancements in new modalities, and the manufacturing needs shaping commercialization of future therapies.
Key Case Studies Areas Include:
- Gamma Delta T Cells & T Cell Engagers
- mRNA, RNA, & NK Therapies
- Multiplex & Combination Cell Therapies
- 3D Bioprinting & Scaffold Development
- Solid Tumours & Expanding Disease Areas (Autoimmune, Neurology, Cardiometabolic)
- Marcus Lehmann - Associate Director, Drug Product Process Development, Satellite Bio
- Nicole Santimauro - Senior Engineer, Manufacturing Science and Technology, Century Therapeutics, Inc.
- George Yuechen Zhu - Staff Scientist, Bayer AG
A Representative from Single Use Support
- Wei-Chiang Chen - Associate Director, BioProcess Analytics, Genomic Medicine Unit, Sanofi
- Jun Li - Associate Director, Upstream Process Development, Gene Therapy, Ultragenyx Pharmaceutical
A Representative from Intertek
- Reagan Jarvis - Chief Executive Officer and Co-founder, Anocca
- Shankar Swaminathan, PhD - Team Lead, Drug Product Development, CMC-Tech Ops, Astellas Institute for Regenerative Medicine
- Jeron Chen - Head of Data Science and Payload Innovation, Voyager Therapeutics
- Kat Kozyrytska - Managing Director, Kozyrytska Consulting